The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine

Feb 15, 2020Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

How blocking a key head nerve may improve life, disability, depression, anxiety, and sleep in chronic migraine patients

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

Quality of life scores for chronic migraine patients increased from 38 before treatment to 64 after one month and 72 after three months post-GONB.

Significant improvements were observed in quality of life as measured by the 24-Hour Migraine Quality of Life Questionnaire scores after GONB.
Patients experienced a statistically significant reduction in disability, depression, anxiety, and sleep disturbance scores following treatment.
The results indicate that GONB may effectively alleviate symptoms associated with chronic migraine and its comorbid conditions.

AI simplified

OBJECTIVE: The greater occipital nerve block (GONB) with local anesthetics is an effective treatment for chronic migraine (CM). In this study, it was aimed to demonstrate the change in quality of life, depression, anxiety, and sleep disturbance scores before and after treatment in CM patients who underwent GONB and the effectiveness of treatment.

PATIENTS AND METHODS: The study included 84 patients diagnosed as CM according to the International Classification of Headache Disorders III beta version diagnostic criteria. The 24-Hour Migraine Quality of Life Questionnaire (MQoLQ), Migraine Disability Assessment Scale (MIDAS), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), Headache Impact Test (HIT), and Visual Analog Scale (VAS) were applied on patients before GONB treatment and at posttreatment months 1 and 3.

RESULTS: MQoLQ scores, which measured the daily quality of life, were 38 [3-66] before GONB treatment, and 64 [38-88] in the first month and 72 [40-86] in the third month after treatment. In addition, this increase was statistically significant (p < 0.001). Furthermore, we found a statistically significant decrease in disability, depression, anxiety, and sleep disturbance scores after treatment (p < 0.05).

CONCLUSION: In this study, we observed a prominent improvement in quality of life and disability rates of CM patients treated with GONB compared to pretreatment. We also demonstrated that the treatment was effective in comorbid depression, anxiety, and sleep disturbance scores.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

The effect of greater occipital nerve blockade on the quality of life, disability and comorbid depression, anxiety, and sleep disturbance in patients with chronic migraine

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief